Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Drug Companies to Phase Out Animal Antibiotics

March 27, 2014 2:53 pm | by Mary Clare Jalonick | News | Comments

Twenty-five pharmaceutical companies are voluntarily phasing out the use of antibiotics for growth promotion in animals processed for meat, the Food and Drug Administration said Wednesday. Read more...              


GSK Pulls EMA App for Cancer Treatment Combo

March 27, 2014 11:11 am | News | Comments

GlaxoSmithKline announced that it has withdrawn its Marketing Authorization Application to the European Medicines Agency for the use of Mekinist (trametinib) in combination with Tafinlar (dabrafenib) for the treatment of adult patients with unresectable or metastatic melanoma with a BRAF V600 mutation. Read more...


Tampering Forces Massive Alli Recall

March 27, 2014 11:04 am | News | Comments

GlaxoSmithKline Consumer Healthcare is voluntarily recalling all Alli weight loss products from U.S. and Puerto Rico retailers as the company believes that some packages of the product were tampered with and may contain product that is not authentic Alli. Read more...


Novartis Treatment Promising Against Drug-Resistant Lung Cancer

March 27, 2014 10:48 am | News | Comments

Novartis published clinical trial results showing the investigational compound LDK378 (ceritinib) achieved an overall response rate of 58% and a median progression-free survival of seven months in adults with advanced anaplastic lymphoma kinase positive non-small cell lung cancer. Read more...


Germany's Merck Launches Phase 3 Fertility Study

March 27, 2014 10:35 am | News | Comments

Merck announced the enrollment of the first patient into a new Phase 3 study in the area of fertility, marking another step in its efforts to explore innovative solutions in areas of unmet medical need.  Read more...          


New Cancer Drug Targets CEA Protein

March 27, 2014 10:17 am | News | Comments

A new cancer drug, based on further development of a discovery originally made by Cancer Research UK, has entered a clinical trial to target a wide range of cancers. Read more...                      


Takeda, Otsuka to Co-Promote Gastrointestinal Drug in Japan

March 27, 2014 5:26 am | by Takeda | News | Comments

Otsuka Pharmaceutical Co. Ltd. and Takeda Pharmaceutical Co. Ltd. announced that the two firms have entered into a co-promotion agreement in Japan for TAK-438, a drug discovered by Takeda for the treatment of acid-related diseases. Read more...


Stimulant Drugs Can Impair Neuronal Activity

March 26, 2014 2:38 pm | News | Comments

Researchers have discovered impaired neuronal activity in the parts of the brain associated with anticipatory functioning among occasional 18- to 24-year-old users of stimulant drugs. Read more...                


Pfizer's Genotropin Hits Phase 3b Endpoints

March 26, 2014 2:09 pm | News | Comments

Pfizer Inc. announced the top-line results from a Phase 3b study evaluating the 24-month efficacy of Genotropin (somatropin) on the height in small-for-gestational-age (SGA) children 24 to 30 months old. Read more...           


Under Fire, Zohydro Maker Touts Safety Board

March 26, 2014 1:54 pm | by Matthew Perrone, AP Health Writer | News | Comments

After months of criticism over its recently launched painkiller Zohydro, the maker of the powerful narcotic is highlighting an unusual oversight board that it's assembled to try and prevent abuse of the drug. Read more...             


SwRI Wins $8.3M HHS Grant for Cyanide Antidote Development

March 26, 2014 1:38 pm | News | Comments

The U.S. Department of Health and Human Services Biomedical Advanced Research and Development Authority has awarded Southwest Research Institute an $8.3 million contract extension to continue development of a nasal-delivery, first-line treatment system to combat cyanide poisoning. Read more...


Drugs for Terminally Ill Clear New Hurdle

March 26, 2014 1:05 pm | News | Comments

A proposal to allow terminally ill people access to drugs that are still completing clinical trials cleared its first test in the Colorado Legislature on Tuesday. Read more...                      


Pharmacists Urged to Withhold Compounded Execution Drugs

March 26, 2014 12:56 pm | by Andrew Welsh-Huggins, AP Legal Affairs Writer | News | Comments

Several human rights and anti-death penalty groups have asked the American Pharmacists Association to prohibit members from participating in executions, a request that comes as states increasingly turn to pharmacists for lethal injection drugs. Read more...


Gold-Based Drug Shows Promise Against Bone Cancer

March 26, 2014 12:35 pm | News | Comments

A gold-based drug currently used in human and veterinary medicine to manage certain immune diseases may prove useful in combating osteosarcoma, researchers report. Read more...                      


Immunotherapy Data Heralds New Era of Lung Cancer Treatment

March 26, 2014 12:26 pm | News | Comments

For decades, scientists and doctors thought immunotherapy– treatments that harness the immune system to fight a disease– was of marginal benefit in lung cancer. Now, a new class of drugs known as “immunocheckpoint regulators” have shown huge potential in treating the disease. Read more...



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.